These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 1420491

  • 1. Erythropoietin and peritoneal dialysis: the efficacy of intraperitoneal dosing.
    Nissenson AR.
    Perit Dial Int; 1992; 12(4):350-2. PubMed ID: 1420491
    [No Abstract] [Full Text] [Related]

  • 2. Recombinant human erythropoietin in patients on peritoneal dialysis.
    Bargman J.
    Perit Dial Int; 1989; 9(4):245-6. PubMed ID: 2488375
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Comparative pharmacokinetics of recombinant erythropoietin administered by the intravenous, subcutaneous, and intraperitoneal routes in continuous ambulatory peritoneal dialysis (CAPD) patients.
    Boelaert JR, Schurgers ML, Matthys EG, Belpaire FM, Daneels RF, De Cre MJ, Bogaert MG.
    Perit Dial Int; 1989; 9(2):95-8. PubMed ID: 2488207
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Intraperitoneal erythropoietin treatment of children with chronic renal failure.
    Steele BT, Vigneux A.
    Pediatr Nephrol; 1995 Jun; 9(3):359-60. PubMed ID: 7632534
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Statement on the clinical use of recombinant erythropoietin in anemia of end-stage renal disease. Ad Hoc Committee for the National Kidney Foundation.
    Am J Kidney Dis; 1989 Sep; 14(3):163-9. PubMed ID: 2672796
    [No Abstract] [Full Text] [Related]

  • 9. Intraperitoneal administration of recombinant human erythropoietin.
    Frenken LA, Struijk DG, Coppens PJ, Tiggeler RG, Krediet RT, Koene RA.
    Perit Dial Int; 1992 Sep; 12(4):378-83. PubMed ID: 1420497
    [Abstract] [Full Text] [Related]

  • 10. Efficacy of once- versus thrice-weekly subcutaneous recombinant human erythropoietin in children receiving continuous cycling peritoneal dialysis.
    Ongkingco JR, Ruley EJ, Turner ME, Fragale MR.
    Am J Nephrol; 1994 Sep; 14(1):14-8. PubMed ID: 8017476
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Erythropoietin in continuous ambulatory peritoneal dialysis: experience with subcutaneous administration.
    Eisele G, Bailie GR, Clement C, Wong E.
    Perit Dial Int; 1992 Sep; 12(1):34-6. PubMed ID: 1543777
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Erythropoietin use in peritoneal dialysis patients.
    Zimmerman SW, Johnson CA.
    Am J Kidney Dis; 1991 Oct; 18(4 Suppl 1):38-41. PubMed ID: 1928078
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Anemia and erythropoietin in hemodialysis and continuous ambulatory peritoneal dialysis.
    Korbet SM.
    Kidney Int Suppl; 1993 Feb; 40():S111-9. PubMed ID: 8445832
    [No Abstract] [Full Text] [Related]

  • 20. Effect of recombinant human erythropoietin on anemia and dialysis: efficiency in patients undergoing CAPD.
    Schollmeyer P, Lubrich-Birkner I, Steinhauer HB.
    Contrib Nephrol; 1990 Feb; 87():95-104. PubMed ID: 2093545
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.